Macromolecular Non-Active Ingredients TRIZ Cases
- Receptor-Targeting Conjugate Linker Tuning for Rapid Tumor Imaging
Linker and half-life tuning help receptor-targeting conjugates bind tumors quickly while clearing plasma fast enough for sustained high contrast.
- Noble Metal Cannabinoid Comestibles with Cellular Microencapsulation
Cellular microencapsulation improves cannabinoid solubility, stability, and dosing uniformity.
- Saposin Lipoprotein Particles via Support-Bound Self-Assembly
Selective binding enables saposin lipoprotein particles to self-assemble on supports, simplifying immobilization and component recycling.
- Poly-ion Complex Micelle Hydrazone Crosslinking
Hydrazone crosslinks stabilize block copolymer micelles against ionic disruption, preventing premature drug release.
- Amphiphilic Thioether Block Copolypeptides for Narrow Chain Length Distribution
Amphiphilic thioether block copolypeptides form well-defined nanostructures through controlled synthesis and chemical modification.
- Oral Retention Composition Using Shellac-Coated Functional Substances
Shellac or zein coating on functional substances mixed with acidic polysaccharides extends oral retention time.
- Nervonic Acid Cyclodextrin Complex for ALD Treatment
Cyclodextrin-mediated nervonic acid formulations reduce toxic VLCFA accumulation without Lorenzo's oil cardiotoxicity.
- Desiccated Liposome Formulation for Transmucosal Delivery
Desiccated liposomes on a micronized powder base bypass hepatic first-pass metabolism to improve bioavailability.
- Cyclodextrin Polymer Synthesis via Direct-Melt Polycondensation
Direct-melt polycondensation eliminates aqueous solvents to boost cyclodextrin polymer yields above 80 percent.
- Nanoparticle D20 Tag Targeting Inflamed Tissues
D20 tag conjugated nanoparticles accumulate in inflamed tissues via protein uptake, avoiding antibody-induced neutrophil impairment.
- Nanoparticle Solution Manufacturing via Ultrasonic Homogenization
Ultrasonic homogenization disperses active pharmaceutical ingredients into nanoparticles to prevent aggregation and enhance bioavailability.
- Transdermal Patch Base Odor Suppression via Copolymer
A transdermal patch base uses a methyl acrylate copolymer to mask unpleasant odors from gelatin and polyvinyl alcohol.
- Dextran-Based CD206 Targeting Compounds for Macrophage Therapy
Dextran-based compounds bind mannose units to CD206 receptors on macrophages for targeted cellular accumulation.
- Stable Microcapsule Powder via Twice-Embedded Emulsion
Twice-embedded emulsion spray granulation prevents nutrient degradation and objectionable odors during homogenization.
- Cyclodextrin Derivatives for Uniform Pharmaceutical Composition
Selective primary face modification eliminates regioisomer mixtures, ensuring consistent pharmaceutical utility and stable drug formulations.
- PNA-RNA Hybrid for siRNA Stability
A peptide nucleic acid hybrid binds to RNA molecules to enhance in vivo stability while maintaining gene silencing efficiency.
- Polypeptide Block Copolymer Micelles for pH-Targeted Drug Delivery
A polypeptide-based block copolymer self-assembles into micelles that respond to pH changes.